Sotorasib for previously treated KRAS G12C mutated, locally advanced or metastatic non-small-cell lung cancer [ID3780]

Research output: Book/ReportReportProfessional

Original languageEnglish
Commissioning bodyNational Institute for Health and Care Excellence
Publication statusPublished - 30-Mar-2022

Keywords

  • Single Technology Appraisal
  • Sotorasib
  • non-small-cell lung cancer

Cite this